Get 20% lifetime commission for referring investors to digrin.com
here.
CytoDyn Inc. (CYDY) Financials
CYDY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Aug. 31, 2026 | 19.1 million | 117.1 million |
| May 31, 2026 | 14.0 million | 123.7 million |
| Feb. 28, 2026 | 18.5 million | 122.8 million |
| Nov. 30, 2025 | 8.9 million | 128.7 million |
CYDY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Aug. 31, 2026 | -7.7 million | 524000 |
| May 31, 2026 | -4.9 million | 823000 |
| Feb. 28, 2026 | -5.5 million | 445000 |
| Nov. 30, 2025 | -4.4 million | 183000 |
CYDY Net Income
No data available :(
CYDY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Aug. 31, 2026 | 16.4 million | 23.8 million | - |
| May 31, 2026 | 11.9 million | 26.3 million | 53000 |
| Feb. 28, 2026 | 15.7 million | 27.2 million | 34000 |
| Nov. 30, 2025 | 5.0 million | - | 69000 |
CYDY Shares Outstanding
CYDY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Aug. 31, 2026 | - | 4.5 million | 2.1 million | - |
| May 31, 2026 | - | 4.5 million | 2.3 million | - |
| Feb. 28, 2026 | - | 4.6 million | 1.7 million | - |
| Nov. 30, 2025 | - | 3.3 million | 1.8 million | - |
CYDY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Aug. 31, 2026 | - | 19000 |
| May 31, 2026 | - | 4000 |
| Feb. 28, 2026 | - | 4000 |
| Nov. 30, 2025 | - | 5000 |
CYDY
Price: $0.23
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.03 USD
P/E Ratio: -7.82
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 272.6 million